U.S. Modifies Chip Ban, Paving the Way for H200 Sales to China

The United States has once again legally eased export controls on the sale of Nvidia’s H200 chips to China.

On January 14, the Bureau of Industry and Security (BIS), under the U.S. Department of Commerce, amended its export control regulations to relax restrictions on high-performance chips. The new thresholds allow for the export of chips with a Total Processing Performance (TPP) of less than 21,000 and a total DRAM bandwidth of less than 6,500 GB/s. This adjustment effectively creates a legal pathway for products such as Nvidia (NVDA) H200 and AMD MI325X to be exported.

A veteran researcher of technology policy noted that this adjustment constitutes a formal rule change, providing a clear legal basis for future transactions.

The revision of these regulatory details is tied to the U.S. government’s official announcement regarding the issuance of export licenses for the H200 and MI325X to mainland China. Because previous regulations—specifically the “October 7 Rule” of 2022 and the “October 17 Rule” of 2023—imposed strict limits on TPP and memory bandwidth, the act of granting new licenses would have conflicted with existing standards without these formal amendments.

“It isn’t as simple as saying ‘you can sell now’ and sales begin immediately; following formal legal procedures takes time,” explained another tech policy researcher. “Simply approving licenses without updating the export control regulations would have been inconsistent with the regulatory framework.”

New Standards and Restrictive Conditions

Records show that the “October 17 Rule” of 2023 required licenses for any chip export to mainland China or Macau that met specific criteria ($TPP \ge 4,800$, or $TPP \ge 1,600$ with a performance density $\ge 5.92$), with a policy of “presumption of denial.” That rule also introduced the concept of “Total DRAM Bandwidth,” placing any chip with a bandwidth $\ge 4,100 \text{ GB/s}$ under control.

It is important to note that the latest adjustment includes several new restrictive conditions:

  • Supply Certification: Applicants (such as Nvidia and AMD) must prove there is sufficient supply for the U.S. market and that exports to China will not delay orders for U.S. customers or impact global foundry capacity.
  • Volume Cap: Exporters must commit that the volume of products exported does not exceed 50% of their total sales within the United States.
  • Non-Military Use: The products must not be used for military purposes.
  • Third-Party Testing: Every shipment must undergo independent testing at a third-party laboratory located within the United States.

Financial Projections and Strategic Motivation

Market data indicates that Nvidia (NVDA) has reserved 660,000 CoWoS capacity units from TSMC for 2026. If 10% (66,000 wafers) is allocated to the H200—assuming 29 chips per wafer—the total output for the H200 in 2026 is expected to reach 1.9 million units. Under the BIS volume cap, the U.S. and China markets would be allocated approximately 1.266 million and 633,000 units, respectively.

Based on an estimated price of 1.4 million RMB for an 8-GPU module, the H200 could contribute over $47.6 billion in revenue to Nvidia in 2026. Of this, the China market could account for nearly $16 billion—a figure expected to exceed the combined 2025 revenue of all currently listed domestic Chinese AI chip companies.

A key factor in the decision to allow these exports is that the U.S. government will take a 25% revenue share. Based on the projected $16 billion in H200 revenue from China, the U.S. government stands to gain roughly $4 billion from export licenses for this single product alone.

“Inventory Clearing” and Ongoing Restrictions

However, many industry insiders view the BIS move to grant export licenses for the H200 as a way to help Nvidia (NVDA) clear existing inventory. Crucially, the U.S. has not lifted restrictions on the contract manufacturing (foundry) of Chinese AI chips with similar performance and specifications. In other words, the policy allows the sale of products at a certain performance level while continuing to prevent China from manufacturing its own equivalent hardware.

Simultaneously, while the executive branch adjusts regulations to facilitate H200 licenses, the U.S. legislative branch is pushing through another law.

On January 12 local time, the U.S. House of Representatives passed the Remote Access Security Act with a vote of 369 to 22 (39 abstentions). This bill aims to restrict the use of cloud platforms like Google and Amazon to remotely access advanced computing power for training AI models. This move could potentially disrupt the collaborative construction of data centers overseas.

The aforementioned researcher emphasized that if the bill is passed by the Senate and signed into law, such international projects may have to be withdrawn.

Musk Slams Apple-Google Partnership, Alleging “Unreasonable Concentration of Power”

Elon Musk, the world’s wealthiest person, launched a scathing critique on Monday against the new partnership between Apple (AAPL) and Alphabet (GOOGL), claiming it grants the latter an “unreasonable concentration of power.”

Google and Apple announced a new multi-year cooperation agreement on Monday, though specific financial terms were not disclosed.

Under the agreement, Apple will utilize Google’s Gemini model to power a new version of Siri, set to launch later this year. This collaboration deepens the alliance between the two tech giants in the AI era and further solidifies Google’s position in its competition against OpenAI.

In a joint statement, the two companies said: “After a thorough evaluation, Apple determined that Google’s AI technology provides the most capable underlying support for Apple Foundation Models and is excited about the new innovative experiences this will unlock for Apple users.”

Musk responded on his social media platform X, stating: “Given that Google also controls Android and Chrome, this looks like an unreasonable concentration of power.”

Musk founded his own AI company, xAI, to compete with major industry players like OpenAI.

In contrast to Musk’s criticism, Dan Ives, an analyst at Wedbush Securities, believes the deal is a “positive win” for both Apple and Google. He noted that for Google, the partnership serves as a major validation of its status as a top-tier foundation model provider. For Apple, it represents a significant step in accelerating its AI strategy toward 2026 and beyond.

Apple had previously considered partnering with OpenAI or Anthropic to have ChatGPT or Claude power the new Siri but ultimately selected Google’s Gemini. Last November, Google launched its Gemini 3 model, which received widespread acclaim for its performance.

The latest agreement builds upon years of existing collaboration, as Google has long been the default search engine on Apple devices. This partnership not only drives massive traffic to Google but also generates tens of billions of dollars in annual revenue for Apple.

Apple currently has approximately 2.4 billion active iOS devices and 1.5 billion iPhones in use, representing one of the largest installed bases among consumer electronics companies.

Tempus AI Projects 83% Revenue Surge for 2025; Total Contract Value Hits Record High of Over $1.1 Billion

Tempus AI (TEM), a leading technology company dedicated to advancing precision medicine through artificial intelligence, saw its shares jump more than 12% in early trading.

The rally followed the company’s release of its preliminary, unaudited financial summary for the fourth quarter and full year ended December 31, 2025. Tempus reported 2025 revenue of approximately $1.27 billion, representing a year-over-year increase of about 83%. Organic growth, excluding contributions from the Ambry Genetics acquisition, stood at approximately 30%.

Segment Performance and Growth Drivers

According to the preliminary data, the company’s Genomics (Diagnostics) business generated approximately $955 million in revenue for 2025, up 111% year-over-year. This growth was primarily driven by a 26% increase in oncology testing volume and a 29% increase in hereditary testing volume.

The Data and Services (Data & Applications) business reached $316 million in revenue, a 31% increase year-over-year, largely supported by a 38% growth in its Insights business.

Furthermore, Tempus AI announced that its Total Contract Value (TCV) exceeded $1.1 billion as of December 31, 2025, marking a new record for the company.

Fourth Quarter Highlights

For the fourth quarter of 2025, Tempus recorded revenue of approximately $367 million, an 83% increase year-over-year:

  • Genomics (Diagnostics): Revenue was approximately $266 million, up 121%, driven by a 29% rise in oncology testing and a 23% rise in hereditary testing volume.
  • Data and Services: Revenue reached approximately $100 million, a 25% increase. Notably, excluding the impact of the AstraZeneca warrants from Q4 2024, the Insights business grew by 68%.

CEO Commentary and 2026 Outlook

“2025 was an exceptional year for Tempus, with both of our product lines exceeding the expectations we set at the beginning of the year,” said Eric Lefkofsky, Founder and CEO of Tempus. “In our Diagnostics business, volume growth for our genomics (oncology) products has accelerated for three consecutive quarters, reaching its highest unit growth rate in years.”

Lefkofsky added, “Our Data and Services business performed even more strongly, with Q4 revenue hitting a record $100 million. We enter 2026 with extraordinary momentum, as growth in both core businesses accelerates and begins to unlock the financial leverage inherent in our platform. With AI serving as a catalyst across all our products, we are very excited for the year ahead.”